Interacting Drugs |
Amlodipine, olmesartan, and hydrochlorothiazide vs CYP3A4 Inhibitors (Strong) |
Security Level |
 |
Mechanism |
CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates. |
Management |
Consider therapy modification |
Amlodipine, olmesartan, and hydrochlorothiazide vs CYP3A4 Inhibitors (Strong)
Post Review about Amlodipine, olmesartan, and hydrochlorothiazide vs CYP3A4 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Amlodipine, olmesartan, and hydrochlorothiazide
Other Interactions of CYP3A4 Inhibitors (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.